EV
Eric Venker
President & Immunovant CEO

Eric Venker insider trades: Roivant Sciences (ROIV) stock sales

President & Immunovant CEO, Roivant Sciences Last trade Nov 3, 2026 90 Form 4 filings
$73.5M
Sold, last 12 months
15 sales
$0
Bought, last 12 months
0 buys
61
Open-market trades
since 2022
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Eric reports to the SEC

Open-market buys and sales

61 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 3, 2026ROIV↓ Sell10b5-1$7.3M
Oct 28, 2026ROIV↓ Sell10b5-1$7.3M
Oct 20, 2026ROIV↓ Sell10b5-1$7.0M
Oct 2, 2026IMVT↓ Sell$120K
Sep 30, 2026ROIV↓ Sell10b5-1$7.3M
Aug 28, 2026ROIV↓ Sell10b5-1$7.2M
Jul 27, 2026ROIV↓ Sell$7.0M
Jul 2, 2026IMVT↓ Sell$119K
May 22, 2026ROIV↓ Sell$6.1M
Apr 20, 2026ROIV↓ Sell$5.9M
Apr 2, 2026IMVT↓ Sell$343K
Feb 13, 2026ROIV↓ Sell$5.3M
Jan 12, 2026ROIV↓ Sell$4.4M
Dec 9, 2025ROIV↓ Sell10b5-1$4.2M
Nov 7, 2025ROIV↓ Sell10b5-1$4.0M
Oct 17, 2025ROIV↓ Sell10b5-1$14.5M
Oct 13, 2025ROIV↓ Sell10b5-1$2.0M
Oct 8, 2025ROIV↓ Sell10b5-1$10.8M
Sep 23, 2025ROIV↓ Sell10b5-1$25.5M
Aug 20, 2025ROIV↓ Sell10b5-1$1.2M
Jul 21, 2025ROIV↓ Sell$1.2M
Jun 20, 2025ROIV↓ Sell$1.1M
Jun 3, 2025ROIV↓ Sell$11.2M
May 20, 2025ROIV↓ Sell10b5-1$1.1M
Apr 21, 2025ROIV↓ Sell10b5-1$1.0M
Mar 24, 2025ROIV↓ Sell10b5-1$8.2M
Feb 20, 2025ROIV↓ Sell$1.1M
Feb 13, 2025ROIV↓ Sell$4.6M
Jan 21, 2025ROIV↓ Sell10b5-1$1.1M
Dec 30, 2024ROIV↓ Sell$4.1M
Dec 20, 2024ROIV↓ Sell10b5-1$1.1M
Nov 20, 2024ROIV↓ Sell10b5-1$1.1M
Oct 21, 2024ROIV↓ Sell$1.2M
Feb 9, 2024ROIV↓ Sell10b5-1$1.1M
Oct 5, 2023ROIV↓ Sell10b5-1$12.5M
Sep 27, 2023ROIV↓ Sell10b5-1$6.5M
Sep 8, 2023ROIV↓ Sell10b5-1$1.3M
Sep 6, 2023ROIV↓ Sell10b5-1$1.1M
Aug 14, 2023ROIV↓ Sell10b5-1$711K
Aug 3, 2023ROIV↓ Sell10b5-1$532K
Aug 2, 2023ROIV↓ Sell10b5-1$2.3M
Jul 27, 2023ROIV↓ Sell10b5-1$1.4M
Jul 24, 2023ROIV↓ Sell10b5-1$4.2M
Jun 9, 2023ROIV↓ Sell10b5-1$3.0M
May 23, 2023ROIV↓ Sell10b5-1$4K
May 9, 2023ROIV↓ Sell10b5-1$2.2M
May 8, 2023ROIV↓ Sell10b5-1$1.3M
May 3, 2023ROIV↓ Sell10b5-1$2.4M
Apr 28, 2023ROIV↓ Sell10b5-1$1.9M
Jan 5, 2023ROIV↓ Sell$193K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ROIV insiders

Open-market trades in the last 12 months

About Eric Venker's insider trades

Eric Venker is President & Immunovant CEO at Roivant Sciences (ROIV). Since Mar 25, 2022, Eric has reported no open-market purchases and 61 sales worth $211.5M on SEC Form 4. In the last 12 months: 15 sales ($73.5M).

42 sales (73% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include option exercises (46 filings), shares withheld for taxes (25 filings), other transactions (12 filings), grants and awards (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ROIV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.